Navigation Links
Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
Date:3/17/2008

sed into formal preclinical studies including IND-enabling toxicology studies. This program will lead to the submission of an Investigational New Drug (IND) application with the US Food and Drug Administration(FDA) in the fourth quarter of 2008. The preclinical development program has already been considered by the FDA in pre-IND reviews, including a face-to-face meeting with FDA reviewers last month.

"The accumulated data for CYT387 clearly indicates that this compound has an excellent potency and safety profile for the treatment of patients with MPDs. We are aggressively progressing this compound through formal preclinical studies with the aim of beginning clinical trials by the end of this year," said Mr. Andrew Macdonald, CEO of Cytopia.

About JAK2

The discovery of a specific single activating mutation in the JAK2 enzyme in MPDs in 2005 has focused attention on developing a therapy for these diseases through selective inhibition of JAK2. To successfully address these chronic diseases with a JAK2 inhibitor, the specificity and resultant tolerability profile is a key element of the product profile required for a "best in class" inhibitor.

CYT387 is a specific JAK2 inhibitor with excellent potential for safe and efficacious chronic human dosing. It has been derived from Cytopia's knowledge of basic biology of JAK kinases, a strong structural biology program that has delivered multiple co-crystal structures of JAK2 complexed with inhibitors, and the subsequent development of an extensive chemical library of JAK2 inhibitors through an integrated computational and medicinal chemistry platform.

Cytopia is developing a suite of JAK2 inhibitors for multiple indications including the treatment of certain cancers, particularly lymphomas and solid tumors where JAK2 has been shown to be up-regulated, and for cardiovascular diseases such as pulmonary hypertension.

About Cytopia

Cytopia Ltd is an Australian biotechnology company
'/>"/>

SOURCE Cytopia Limited
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related medicine technology :

1. Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development
2. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
3. Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
4. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
5. Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
6. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
7. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
8. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
9. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
10. New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
11. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... June 17, 2013  As the Share Repurchase Resolution has ... Offer for Elan Corporation, plc (NYSE: ELN ) ... outcome of the Proceedings referred to below and any consequent ... to be effective to the extent that it would have ... of the Share Repurchase Resolution being passed. There can be ...
(Date:6/17/2013)... PARSIPPANY, N.J. , June 17, 2013 Actavis, ... United States Supreme Court has reversed the decision of the ... affirmed the District Court,s ruling granting Actavis, motion to dismiss ... .  The Supreme Court,s reversal was the result of a ... the FTC,s proposed "quick look" approach and adopted the traditional ...
(Date:6/17/2013)... , June 17, 2013 The Biozoom ... portable, hand held device for the non-invasive transdermal ... human body. It replaces expensive, time consuming and ... a button, the Biozoom scanner reflects a beam ... Zeiss—and measures the reflection. Using the scanner, researchers ...
Breaking Medicine Technology:Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 2Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 3Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 4Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 5Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 6Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 7Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 8Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 9Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 10U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 3University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 2University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 3University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 4
... Sheffield Bio-Science, a leading global pharmaceutical supplier of superior ... markets, has been awarded the distinguished 2010 Lilly Global Supplier Award. ... The ... and services for Eli Lilly and Company over the years and ...
... ATLANTA , July 12 Holon, the new ... Medication Management solution. , ... Leveraging the Holon Process Adaptive Interoperability Framework, ... your current medication management solution by automating the collection and ...
Cached Medicine Technology:Sheffield Bio-Science Wins 2010 Lilly Global Supplier Award 2Holon: The Process Adaptive Interoperability Framework 2
(Date:6/17/2013)... Essential tremor (ET) is the most common ... people in the United States, and millions more worldwide. ... causes ET, there are no medications specifically designed to ... Tremor© is the International Essential Tremor Foundation’s annual research ... cure for this life-altering neurological condition. , “Although millions ...
(Date:6/17/2013)... of people who registered themselves as organ donors 21-fold ... social media might be an effective tool to address ... The gains were made in May 2012 when the ... share their organ donor status with friends and provided ... department of motor vehicle websites. The findings are being ...
(Date:6/17/2013)... June 17, 2013 Bust’DD (pronounced ‘busted’), a ... and well-fitting to women with large busts, will soon launch ... two women who understand the problem of ill-fitting bras and ... women. Their goal is to raise at least $25,000 to ... offering their bras on a wide scale. , In order ...
(Date:6/17/2013)... 2013 The producers of Impact with ... of reports highlighting how sustainable farming techniques are helping ... and their demand on food supplies. , Impact ... series airing in markets around the country on public ... Sheen, who is marking the start of his second ...
(Date:6/17/2013)... As da Vinci robot lawsuit claims ... Liebhard LLP notes that a recent report aired on ... disturbing robotic surgery complications alleged to have been caused by ... June 14th broadcast revealed that the U.S. Food & Drug ... Vinci patients who suffered burns, cuts and infections since 2007. ...
Breaking Medicine News(10 mins):Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:The Facebook effect: Social media dramatically boosts organ donor registration 2Health News:The Facebook effect: Social media dramatically boosts organ donor registration 3Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 3Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 3
... the Children of Love Canal Are Not Counted In the ... Speak &,Ask What Have We Learned?, FALLS CHURCH, Va., ... for Health, Environment & Justice:, WHAT:, Press Conference ... Love Canal once stood., Rain or Shine, WHEN:, ...
... YORK, July 26, 2008 The following news tips are ... 2008 International Conference to be held in Chicago from July ... specific date and time. , Brain Atrophy and Biomarkers ... Susan de Santi, Ph.D., Associate Professor, Department of Psychiatry, NYU ...
... FE SPRINGS, Calif., July 29 IQAir announced ... (USOC) with ultra-high,efficiency air cleaning for USA athletes ... the optimum performance environment., (Photo: http://www.newscom.com/cgi-bin/prnh/20080729/LATU099 ... able to support the performance efforts of the,USOC ...
... SAN JOSE, Calif., July 29 VNUS(R) Medical,Technologies, Inc. (Nasdaq: ... for the full year 2008. Full-year 2008 net income is ... income of $0.77,to $0.85 per share which is changed from ... or income of $0.68 to $0.74 per,share., ABOUT VNUS ...
... AGAWAM, Mass., July 29 Microtest Laboratories has,launched ... compounding pharmacies,in the U.S. that have yet failed ... 797) regulations. Microtest also announced,its offer of a ... USP 797 compliance level and corresponding,preparation., Pharmacies ...
... Health and Charitable Care and Coverage, OAKLAND, ... it has approved more than 415 community benefit ... second quarter of 2008.,The quarter,s contributions continue to ... a measurable impact on the health of,its communities., ...
Cached Medicine News:Health News:30 Years After State of Emergency Declared at Love Canal, NY Closing the 99th Street School Triggering the Federal Superfund Program; Schools & Communities Across the Nation Still at Risk of Toxic Contamination 2Health News:New Alzheimer's predictors advance earlier detection 2Health News:New Alzheimer's predictors advance earlier detection 3Health News:New Alzheimer's predictors advance earlier detection 4Health News:New Alzheimer's predictors advance earlier detection 5Health News:New Alzheimer's predictors advance earlier detection 6Health News:New Alzheimer's predictors advance earlier detection 7Health News:New Alzheimer's predictors advance earlier detection 8Health News:IQAir to Provide U.S. Athletes With Ultra-High Efficiency Air Cleaning at the Beijing 2008 Olympic Games 2Health News:VNUS Revises Upward Full-Year 2008 Net Income Guidance 2Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 2Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 3Health News:Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008 2Health News:Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008 3
... The QuickVue Influenza A+B test allows ... influenza type A and type B ... wash and/or nasal aspirate specimens. The ... in the rapid differential diagnosis of ...
... Antibody Detection Assay is a single use, ... (first step) detection of IgG and IgM ... or whole blood. Rapid turnaround time, ease ... Wampole PreVue B. burgdorferi antibody detection test ...
... Conforming to U.S. and international ... Nephew's TC-100 Screw and Plating System* ... and ease of use for open ... However, the TC-100 system works well ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Medicine Products: